| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||
Net loss | ||||||||
-29,721 | -26,050 | -25,495 | -23,784 | -21,296 | -20,545 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation | ||||||||
40 | 39 | 43 | 36 | 30 | 23 | 0 | 0 | 0 |
Changes in fair value of Series C redeemable convertible preferred stock liability | ||||||||
- | - | - | - | - | 2,105 | 0 | 0 | 0 |
Changes in fair value of obligation for loan success fee | ||||||||
- | 215 | 226 | 273 | 178 | 138 | 0 | 0 | 0 |
Accretion/accrual of term loan discounts and debt issuance costs | ||||||||
- | - | - | - | - | 60 | 0 | 0 | 0 |
Stock-based compensation | ||||||||
1,711 | 1,127 | 939 | 689 | 554 | 496 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Receivables | ||||||||
-25 | 374 | 84 | 164 | 83 | 135 | 0 | 0 | 0 |
Prepaid expenses | ||||||||
-613 | 243 | 233 | 1,318 | 1,399 | 1,345 | 0 | 0 | 0 |
Accounts payable | ||||||||
1,556 | 777 | -390 | 1,600 | -228 | 66 | 0 | 0 | 0 |
Accrued expenses | ||||||||
1,943 | 1,416 | 3,169 | 3,883 | 2,451 | 772 | 0 | 0 | 0 |
Security deposit | ||||||||
- | - | - | - | - | 33 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-23,670 | -23,093 | -21,623 | -17,882 | -18,431 | -18,289 | 0 | 0 | 0 |
Investing activities | ||||||||
Acquisitions of property, equipment and leasehold improvements | ||||||||
- | 9 | 101 | 100 | 110 | 158 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||
- | -9 | -101 | -100 | -110 | -158 | 0 | 0 | 0 |
Financing activities | ||||||||
Repayments of term loan | ||||||||
- | - | - | - | - | 4,813 | 0 | 0 | 0 |
Proceeds from exercises of stock options | ||||||||
- | 38 | 38 | 38 | 24 | 13 | 0 | 0 | 0 |
Proceeds from sale of Series C redeemable convertible preferred stock, net of issuance costs | ||||||||
- | 9,963 | 0 | 0 | 0 | - | - | - | - |
Deferred offering costs | ||||||||
- | - | - | - | 0 | - | - | - | - |
Net cash provided by financing activities | ||||||||
- | 73,213 | 71,705 | 82,311 | 15,528 | 3,629 | 0 | 0 | 0 |
Net cash increase (decrease) | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net cash increase (decrease) | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Supplemental disclosure of cash flow information | ||||||||
Interest paid | ||||||||
- | - | - | - | - | 152 | 0 | 0 | 0 |
State research tax credits exchanged for cash | ||||||||
- | - | - | - | - | 35 | 0 | 0 | 0 |
Supplemental disclosure of non-cash financing activities | ||||||||
Deferred offering costs | ||||||||
- | - | - | - | 0 | - | - | - | - |
Deferred offering costs | ||||||||
- | - | - | - | 0 | - | - | - | - |
Dividends accrued on redeemable convertible preferred stock | ||||||||
- | 2,239 | 3,706 | 5,068 | 5,675 | 5,402 | 0 | 0 | 0 |
Accretion on redeemable convertible preferred stock | ||||||||
- | -1,535 | -1,631 | -1,535 | -378 | -370 | 0 | 0 | 0 |